QMLGOCBMNov 18, 2022

Forecasting labels under distribution-shift for machine-guided sequence design

arXiv:2211.10422v14 citationsh-index: 13
Originality Incremental advance
AI Analysis

This addresses a critical bottleneck in machine-guided sequence design for biotechnology and healthcare, though it is an incremental improvement over current tools.

The paper tackles the problem of assessing the likelihood that designed biological sequences meet desired quality before costly lab validation, by proposing a forecasting method that outperforms existing naive model-score baselines.

The ability to design and optimize biological sequences with specific functionalities would unlock enormous value in technology and healthcare. In recent years, machine learning-guided sequence design has progressed this goal significantly, though validating designed sequences in the lab or clinic takes many months and substantial labor. It is therefore valuable to assess the likelihood that a designed set contains sequences of the desired quality (which often lies outside the label distribution in our training data) before committing resources to an experiment. Forecasting, a prominent concept in many domains where feedback can be delayed (e.g. elections), has not been used or studied in the context of sequence design. Here we propose a method to guide decision-making that forecasts the performance of high-throughput libraries (e.g. containing $10^5$ unique variants) based on estimates provided by models, providing a posterior for the distribution of labels in the library. We show that our method outperforms baselines that naively use model scores to estimate library performance, which are the only tool available today for this purpose.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes